Prevention of Depression in Patients Being Treated for Head and Neck Cancer.

Trial Profile

Prevention of Depression in Patients Being Treated for Head and Neck Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Apr 2014

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Acronyms PROTECT
  • Most Recent Events

    • 22 May 2013 Results presented at the 166th Annual Meeting of the American Psychiatric Association.
    • 22 Mar 2013 Primary endpoint 'Quick-Inventory-of-Depressive-Symptomology-Self-Report' has been met according to results presented at the 166th Annual Meeting of the American Psychiatric Association.
    • 08 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top